// App-Quantinova.ai

TCT-210 : Clinical Outcomes Following Resolute Zotarolimus-eluting Stent Implantation in Diabetic versus Non-Diabetic Patients Suitable for Percutaneous Coronary Revascularization: Insights From a Multicenter Italian Registry

Researchers

Presenter

  • Alfonso Ielasi

Principal Investigators

  • Azeem Latib

  • Francesco Burzotta

  • Francesco Summaria

  • Maria De Vita

  • Angelo Anzuini

  • Claudio Larosa

  • Francesco Della Rovere

  • Saverio Lanzone

  • alessandro manzoli

  • Francesca Giovannelli

Medical Centers

  • Istituto Clinico Humanitas Mater Domini, Castellanza (VA), Italy

  • E.O. Ospedali Galliera, Genova, Italy

  • San Raffaele Scientific Institute, Milan, Italy

  • AZ Ospedaliera S.Andrea, Rome, Italy

  • Ospedale Morgagni Pierantoni, Forli, Italy

  • Catholic University of the Sacred Heart, Rome, Italy

  • Ospedali di Venere, Carbonara (BA), Italy

  • EMO GVM Centro Cuore Columbus/San Raffaele Hospital, Milan, Italy

  • S. Giovanni Hospital, Rome, Italy

  • Policlinico Casilino, Rome, Italy

  • Ospedale Bonomo, Andria (BAT), Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Diabetes

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • ZoMaxx

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved